Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesAn Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration
Alzheimer Disease & Associated Disorders , 09/02/09
Boxer AL et al. – The FTD and SD groups declined on most of the cognitive and behavioral outcome measures, but remained stable on the UPDRS, whereas the progressive nonfluent aphasia group remained relatively stable on the ADAS–cog, NPI, and TFLS, but declined on the UPDRS. Memantine was well–tolerated in these subjects.
Related Articles
Benefit Of Memantine In The Treatment Of Alzheimers Disease Not Proven
ScienceDaily, 10/29/09
Relevance Score: 87%
Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy
European Journal of Neurology, 11/03/09
Relevance Score: 85%
Variability in the Prescription of Cholinesterase Inhibitors and Memantine
Dementia and Geriatric Cognitive Disorders, 11/03/09
Relevance Score: 82%
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Neuropsychiatric Disease and Treatment, 11/04/09
Relevance Score: 80%
Today in Dementia...keeping you current
Receive free subspecialty "5-minute updates" via email
Cognitive impairment following high fat diet consumption is associated with brain inflammation
Journal of Neuroimmunology, 12/14/09
Evaluation of the Usability of a Brief Computerized Cognitive Screening Test in Older People for Epidemiological Studies
Neuroepidemiology , 12/14/09
Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease
Clinical Drug Investigation, 12/14/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/14/09
Epilepsy, sex hormones and antiepileptic drugs in female patients
Expert Review of Neurotherapeutics, 12/14/09
Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease
Clinical Drug Investigation, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor